Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Suso Platero"'
Autor:
Giuseppe Curigliano, Maryland Rosenfeld Franklin, Suso Platero, Kamal S Saini, Steven Anderson
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/394c663236d343a390e86a5a650103a0
Autor:
Xu-Chao Zhang, Jun Wang, Guo-Guang Shao, Qun Wang, Xiaotao Qu, Bo Wang, Christopher Moy, Yue Fan, Zayed Albertyn, Xiayu Huang, Jingyu Zhang, Yang Qiu, Suso Platero, Matthew V. Lorenzi, Enrique Zudaire, Jennifer Yang, Ying Cheng, Lin Xu, Yi-Long Wu
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-12 (2019)
The relationship between genomic alteration and immune context in non-small cell lung cancer (NSCLC) is complex. Here, the authors analyse the molecular and immunological landscape of 245 Chinese patients with NSCLC and find low immune infiltration c
Externí odkaz:
https://doaj.org/article/73c8286a0df443e885f70658074e7476
Autor:
Sen Hong Zhuang, Roland Knoblauch, Zhilong Yuan, Brett Hall, Suso Platero, Ludy van Beijsterveldt, Jaume Capdevila, Jose Antonio Lopez-Martin, Andrés Cervantes, Patrick Schöffski, Luc Dirix, Josep Tabernero
Purpose: Originally isolated on the basis of its ability to induce p53, serdemetan showed potent activity in various preclinical models, inducing S-phase arrest and apoptosis in TP53 wild-type and mutant tumors. This study evaluated the safety and to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f61b6e0f3b9e6b5565701cec26e218b
https://doi.org/10.1158/1078-0432.c.6519323.v1
https://doi.org/10.1158/1078-0432.c.6519323.v1
Autor:
Marco M. Gottardis, Robert Kramer, Gregory Vite, Shen-Jue Chen, Joseph Dinchuk, William R. Foster, Mark E. Salvati, Weifang Shan, Mary Obermeier, J. Suso Platero, Thomas E. Spires, Liang Schweizer, Cheryl A. Rizzo, Janet Dell-John, Mary Ellen Cvijic, Aaron Balog, Maria Jure-Kunkel, Ricardo M. Attar
Supplementary Table 1 from Discovery of BMS-641988, a Novel and Potent Inhibitor of Androgen Receptor Signaling for the Treatment of Prostate Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ea96b450993c30817e08b09d67ecd09
https://doi.org/10.1158/0008-5472.22377966
https://doi.org/10.1158/0008-5472.22377966
Autor:
Edwin Clark, Peter Shaw, Francis Lee, Tai W. Wong, Suso Platero, Craig Fairchild, Xia Han, Karen Reeves, Fei Huang
Supplementary Information and Figures 1-3 from Identification of Candidate Molecular Markers Predicting Sensitivity in Solid Tumors to Dasatinib: Rationale for Patient Selection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1f4b66913786ae46ca0170c762107b4
https://doi.org/10.1158/0008-5472.22371497
https://doi.org/10.1158/0008-5472.22371497
Autor:
Marco M. Gottardis, Robert Kramer, Gregory Vite, Shen-Jue Chen, Joseph Dinchuk, William R. Foster, Mark E. Salvati, Weifang Shan, Mary Obermeier, J. Suso Platero, Thomas E. Spires, Liang Schweizer, Cheryl A. Rizzo, Janet Dell-John, Mary Ellen Cvijic, Aaron Balog, Maria Jure-Kunkel, Ricardo M. Attar
Supplementary Table 2 from Discovery of BMS-641988, a Novel and Potent Inhibitor of Androgen Receptor Signaling for the Treatment of Prostate Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77108c0dff54d0d9d17df83470660395
https://doi.org/10.1158/0008-5472.22377963.v1
https://doi.org/10.1158/0008-5472.22377963.v1
Autor:
Marco M. Gottardis, Robert Kramer, Gregory Vite, Shen-Jue Chen, Joseph Dinchuk, William R. Foster, Mark E. Salvati, Weifang Shan, Mary Obermeier, J. Suso Platero, Thomas E. Spires, Liang Schweizer, Cheryl A. Rizzo, Janet Dell-John, Mary Ellen Cvijic, Aaron Balog, Maria Jure-Kunkel, Ricardo M. Attar
Supplementary Figure and Table Legends 1-2 from Discovery of BMS-641988, a Novel and Potent Inhibitor of Androgen Receptor Signaling for the Treatment of Prostate Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71c30c0ceeb3ee6de838292a026446d0
https://doi.org/10.1158/0008-5472.22377969
https://doi.org/10.1158/0008-5472.22377969
Autor:
Dirk Zielinski, Suso Platero
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::690119870ddc639a9f8568e76dc4b58d
https://doi.org/10.1136/jitc-2022-sitc2022.0156
https://doi.org/10.1136/jitc-2022-sitc2022.0156
Autor:
Dirk Zielinski, Rebekka Vogtmann, Anne Siemon, Christina Koppel, Christina Schipper, Anastasiia Tereshchenko, Suso Platero, Hans-Ulrich Schildhaus
Publikováno v:
Cancer Research. 83:1018-1018
The advent of immune oncology had a significant impact on the stratification of cancer patients in the past few years. Furthermore, immune cell phenotyping of the tumor microenvironment is becoming a tool not only for the identification of novel pred
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0618876faeef880ecf0b3401fa634da8
https://doi.org/10.1158/1538-7445.am2023-1018
https://doi.org/10.1158/1538-7445.am2023-1018
Autor:
Maryland Rosenfeld Franklin, Suso Platero, Kamal S Saini, Giuseppe Curigliano, Steven Anderson
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
The landscape in immuno-oncology (I-O) has undergone profound changes since its early beginnings up through the rapid advances happening today. The current drug development pipeline consists of thousands of potential I-O therapies and therapy combina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::733640279053512a428c2d04fbdb3e48
https://jitc.bmj.com/content/10/1/e003231.full
https://jitc.bmj.com/content/10/1/e003231.full